| |||||
| |||||
Hello Nature readers, | |||||
Mutations in the tumour-suppressor gene CDK13 were first discovered in zebrafish. (NERYXCOM/Shutterstock) | |||||
Cell's broken 'vacuum cleaner' drives cancerMutations in a protein that is responsible for cellular garbage disposal seem to speed up melanoma development. The protein cyclin-dependent kinase 13 (CDK13) usually regulates a team of proteins that clear away mistake-ridden RNA. A study in zebrafish found that this protein malfunctions when mutated, causing defunct RNA to pile up and melanoma to progress faster. "The vacuum cleaner was broken," says oncologist and study leader Megan Insco. The researchers found that around 21% of human melanoma tumours also had CDK13 mutations. New Atlas | 3 min readReference: Science paper (21 April) | |||||
Challenges facing the new NIH headCancer surgeon Monica Bertagnolli has been nominated | |||||
Human genome 2.0More than two decades after the first human genome was sequenced, scientists have completed a draft 'pangenome', which includes the genetic sequences of 47 people from Africa, the Americas, Asia and Europe. "This is like going from black-and-white television to 1080p," says geneticist Keolu Fox. The diversification will help scientists to study the wide variation in human diseases. Nature | 6 min readReference: Nature paper (10 May) | |||||
ACCESS NATURE AND 54 OTHER NATURE JOURNALS Nature+ gives you immediate online access to Nature and 54 other journals. Nature+ is a flexible monthly subscription and is currently available only to personal users in the United States and in the United Kingdom. | |||||
| |||||
Muscle-wasting protein identifiedCachexia, a condition in which the muscles start to degrade in people with cancer and other diseases, seems to be triggered by the protein EDA2 and its receptor. Researchers found that the EDA2 receptor was overexpressed in the skeletal muscles of people and mice with various diseases that cause muscle atrophy. When muscle cells were exposed to the EDA2 protein in the lab, they shrank. And when mice were injected with a virus that expresses this protein, they lost muscle mass at the injection site. This discovery may not yield a pharmaceutical 'magic bullet' that can treat cachexia, but it could be combined with nutritional interventions and exercise to help reverse muscle loss, write molecular immunologists Laura Antonio-Herrera and Andreas Bergthaler. Nature News & Views | 3 min readReference: Nature paper (10 May) | |||||
The EDA2 protein and its receptor (EDA2R) kick off a signalling cascade that results in the expression of two genes — Atrogin1 and Murf1. These genes code for enzymes that control the breakdown of muscle protein. | |||||
More reasons not to smoke after cancerContinuing to smoke or vape after being diagnosed with cancer is associated with greater fatigue, pain and emotional problems. In a study of around 1,400 adult cancer survivors, those who continued to smoke or vape had worse symptoms. Most people try to quit smoking after the shock of a cancer diagnosis, but the majority pick up the habit again. Reference: Cancer paper (22 May) | |||||
Zika study spills natural killer cell secretsWhen a foetus is infected with the Zika virus, maternal immune cells called Natural Killer Cells are recruited to the site. Researchers studying this interaction have discovered how natural killer cells are called to action, a finding that could be repurposed in cancer immunotherapies. Natural killer cells have the receptor NKp46 on their cell surface, which recognizes a protein called calreticulin on the surface of cells under physiological stress, such as Zika-infected cells or cancer cells. When researchers knocked out the gene encoding calreticulin in mice, natural killer cells did a worse job of killing Zika-infected cells. Reference: Nature paper (5 April) | |||||
| |||||
| |||||
Weight gain early in life predicts cancerMen are more likely to be diagnosed with prostate cancer later in life if they put on weight as young adults. Adding a kilogram of weight per year between the ages of 17 and 29 was associated with a 13% increased risk of aggressive prostate cancer and a 27% increased risk of fatal prostate cancer, a yet-to-be-published analysis of a quarter of a million Swedish men found. "Avoiding a steep weight increase that commonly occurs in young adulthood may reduce the risk of incident and fatal prostate cancer," the researchers write. Reference: European Congress on Obesity abstract | |||||
Quote of the week"This is what I do when I'm forwarded information about nonstandard, alternative, or early cancer therapies: I hit delete."People with cancer often receive well-meaning messages from friends and family about early drug trials. But this can offer false hope because many successful mouse studies do not translate into humans, says molecular biologist Jeff Stewart, who was diagnosed with stomach cancer last year. (NPR | 7 min read) | |||||
| |||||
| |||||
| |||||
| |||||
You received this newsletter because you subscribed with the email address: [email protected] Please add [email protected] to your address book. Enjoying this newsletter? You can use this form to recommend it to a friend or colleague — thank you! Had enough? Unsubscribe from Nature Briefing: Cancer. Fancy a bit of a read? View our privacy policy. Forwarded by a friend? Get the Briefing straight to your inbox: subscribe for free. Get more from Nature: Register for free on nature.com to sign up for other newsletters specific to your field and email alerts from Nature Research journals. Nature | The Springer Nature Campus, 4 Crinan Street, London, N1 9XW, United Kingdom Nature Research, part of Springer Nature. |